article thumbnail

PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research

Cannabis Law Report

RespRx, in addition to its clinical research with COPD, has been engaged in select, non-clinical trials to treat cancer and demonstrated effectiveness. Learn more about USMJ’s ecommerce site at www.usmj.com. In conjunction with PAOG’s ongoing IND initiative for RespRx, and PAOG’s connection with U.S. Billion by 2027.

article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. This work will support potential future applications for Investigational New Drugs (INDs) with FDA’s Center for Drug Evaluation and Research (CDER) in humans and animals.

article thumbnail

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Cannabis Law Report

Epsilon also owns a number of medicinal cannabis assets, including the Tetra Health clinic, and the Medimar Platform – an end-to-end ecommerce solution for nutraceuticals and cannabis. The facility consists of its own QC lab and grade D cleanroom space for the manufacture of oral dose format products.

Access 97